SCHEMBL2534813

SCHEMBL2534813

COC(=O)C(C)(C)Oc1cccc(C=O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.49
SRC P12931 1/20 0.46
POLB P06746 2/20 0.46
ALDH1A1 P00352 2/20 0.46
NPC1 O15118 3/20 0.43
RAB9A P51151 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAOA P21397 7/20 0.41
MAOB P27338 7/20 0.41
KMT2A Q03164 3/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PPARA Q07869 2/20 0.40
PPARG P37231 1/20 0.40
MEN1 O00255 2/20 0.40
UNG P13051 1/20 0.40
BLM P54132 1/20 0.40
MCL1 Q07820 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2441567 0.87 FBP1 (0.48) FBP1SRCPOLBALDH1A1NPC1
SCHEMBL2174559 0.84 PPARA (0.51) FBP1SRCPOLBALDH1A1MAOA
SCHEMBL814353 0.84 FBP1 (0.68) FBP1SRCALDH1A1MAOAMAOB
SCHEMBL31072846 0.84 FBP1 (0.68) FBP1SRCALDH1A1MAOAMAOB
SCHEMBL13069642 0.81 CES2 (0.49) NPC1RAB9AKMT2AMAPTSMN1; SMN2
SCHEMBL17967827 0.81 ALDH1A1 (0.50) FBP1ALDH1A1TDP1KMT2AMAPT
SCHEMBL4607275 0.81 CYP3A4 (0.51) FBP1POLBALDH1A1NPC1RAB9A
SCHEMBL14122304 0.80 LMNA (0.50) FBP1POLBALDH1A1NPC1RAB9A
SCHEMBL2518040 0.79 SRC (0.51) SRCPOLBALDH1A1NPC1RAB9A
SCHEMBL5738818 0.78 TP53BP1 (0.43) FBP1SRCNPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4648762-A2 PPARG MODULATORS University of Florida Research Foundation, Incorporated (US) 2025-11-19 EP disclosed
WO-2024151519-A2 PPARG MODULATORS UNIVERSITY OF FLORIDA RESEARCH FOUNDATIN, INCORPORATED (US) 2024-07-18 WO disclosed
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 FBP1 3649/4885SRC 2098/4885POLB 4481/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 FBP1 3649/4885SRC 2098/4885POLB 4481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.